Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherThis Month in JNM

This Month in JNM

Journal of Nuclear Medicine June 2008, 49 (6) 13A-14A;
  • Article
  • Info & Metrics
  • PDF
Loading

PET in cancer immunotherapy: Tumeh and colleagues review current molecular imaging approaches for differentiating metabolically active cancer cells from activated immune cells.
Page 865

Cellular uptake of radioactivity: Bolch reviews recent developments in cellular uptake models of radiopharmaceuticals and previews an article on this topic in this issue of JNM.
Page 869

Peripheral uptake reproducibility: Rudd and colleagues compare the accuracy of 2 methods of measuring short-term 18F-FDG uptake in PET imaging to assess therapies in peripheral artery disease.
Page 871

Phase 1 18F-AH111585 trial: Kenny and colleagues investigate the safety, stability, and tumor distribution kinetics of this novel RGD-based integrin peptide–polymer conjugate and its suitability for use with PET to detect tumors in patients with metastatic breast cancer.
Page 879

Figure

Enhanced metabolism after tumor removal: Scheer and colleagues use 18F-FDG PET to evaluate the metabolic activity of liver metastases before and after resection of primary colorectal tumors and discuss the implications for administration of postoperative antiangiogenic therapy.
Page 887

Figure

Tumor volumes from metabolic rate maps: Visser and colleagues determine tumor volumes in glucose metabolic rate maps, compare these with standardized uptake value maps, and describe the benefits of additional metabolic information in PET-based radiotherapy planning and response monitoring.
Page 892

99mTc-EC20 tumor imaging: Fisher and colleagues measure accumulation percentages of this novel folate receptor–targeted imaging agent in patients with various solid tumors and correlate uptake with immunohistochemistry analyses of receptor expression in biopsied tumor tissue.
Page 899

Figure

123I-MIBG in CHF: Kasama and colleagues explore whether serial 123I-MIBG scintigraphic studies represent a reliable prognostic marker for death and sudden death in patients with congestive heart failure.
Page 907

SPECT attenuation correction in women: Wolak and colleagues assess the performance of attenuation correction in women, using automated quantitative analyses in myocardial perfusion SPECT to avoid bias.
Page 915

Figure

Radioiodine and ophthalmopathy: Sisson and colleagues report on rates of appearance or increase in manifestation of Graves ophthalmopathy in U.S. patients treated with radioiodine for hyperthyroidism.
Page 923

PET in focal epilepsy: O'Brien and colleagues apply decision tree analysis to evaluate the sensitivity, specificity, and cost effectiveness of clinical algorithms that incorporate 18F-FDG PET in the presurgical assessment of medically refractory focal epilepsy.
Page 931

Figure

Dual-modality imaging: Townsend provides an educational overview and perspectives on the development of image fusion techniques and looks at advances and challenges in using image fusion from complementary modalities to provide more complete and accurate assessments of disease.
Page 938

Figure

Camera for sentinel node biopsy: Tsuchimochi and colleagues report on animal studies evaluating the efficacy of a small cadmium telluride γ-camera intended for use in radioguided surgeries.
Page 956

Figure
Figure

Quantitation of CXCR4 expression: Misra and colleagues describe in vivo quantification of this chemokine stromal-derived factor-1α and its receptor and discuss the potential for elucidating mechanisms of cardiac dysfunction in a variety of animal models of disease.
Page 963

Figure

99mTc-lisinopril for ACE imaging: Femia and colleagues detail the synthesis and evaluation of lisinopril probes for imaging angiotensin-converting enzyme expression and highlight the promise for monitoring enzyme expression as a function of cardiac disease progression.
Page 970

Figure

Estradiol-based imaging agent: Nayak and colleagues report on synthesis, biodistribution, and nanoSPECT/CT studies in a new structural class of compounds for potential use in breast and endometrial cancer imaging.
Page 978

Figure

18F-labeled androgen ligands: Parent and colleagues evaluate 2 novel 18F-labeled androgens with potential for use in clinical imaging trials to explore the role of sex hormone–binding globulin in radiotracer delivery of steroidal systems to targeted tissues.
Page 987

Ubiquicidin PET tracers in abscesses: Salber and colleagues compare the distribution of 18F- and 99mTc-labeled ubiquitin compounds in PET imaging of muscle abscesses with the results of anti-Staphylococcus aureus immunofluorescent imaging.
Page 995

Figure

Resolution modeling in PET: Sureau and colleagues assess the impact of resolution modeling during reconstruction on image quality and on estimates of biologic parameters in clinical and phantom brain studies on a high-resolution research tomograph.
Page 1000

Figure
Figure

Statistical analysis of α-particle tracks: Neti and Howell report on a detailed analysis of earlier autoradiographic data on distribution of radioactivity among a population of cells labeled with 210Po.
Page 1009

124I PET dosimetry protocol for DTC: Jentzen and colleagues research the iodine kinetics and lesion dose per administered 131I activity of differentiated thyroid cancer metastases using 124I PET to derive an optimized dosimetry protocol.
Page 1017

Pediatric radiopharmaceutical dosimetry: Treves and colleagues report on the results of a survey of North American pediatric hospitals to determine the range of variability in radiopharmaceutical dosimetry and the implications for variability in radiation-absorbed doses.
Page 1024

ON THE COVER

Atherosclerosis imaging with 18F-FDG PET is useful for detecting inflammation within plaque and monitoring the response to drug therapy. Here, PET and PET/CT images of femoral artery 18F- FDG uptake on days 1 and 14 demonstrate the strong temporal reproducibility of the technique. Measurement of target-to- background ratios may prove useful for assessing both systemic and plaque-focused therapies for atherosclerosis.

Figure

See page 873.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 49 (6)
Journal of Nuclear Medicine
Vol. 49, Issue 6
June 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
This Month in JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
This Month in JNM
Journal of Nuclear Medicine Jun 2008, 49 (6) 13A-14A;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
This Month in JNM
Journal of Nuclear Medicine Jun 2008, 49 (6) 13A-14A;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • ON THE COVER
  • Info & Metrics
  • PDF

Related Articles

  • PET Imaging of Cancer Immunotherapy
  • Further Explorations of Cellular Uptake of Radioactivity
  • Atherosclerosis Inflammation Imaging with 18F-FDG PET: Carotid, Iliac, and Femoral Uptake Reproducibility, Quantification Methods, and Recommendations
  • Phase I Trial of the Positron-Emitting Arg-Gly-Asp (RGD) Peptide Radioligand 18F-AH111585 in Breast Cancer Patients
  • Increased Metabolic Activity of Indolent Liver Metastases After Resection of a Primary Colorectal Tumor
  • Comparison of Tumor Volumes Derived from Glucose Metabolic Rate Maps and SUV Maps in Dynamic 18F-FDG PET
  • Exploratory Study of 99mTc-EC20 Imaging for Identifying Patients with Folate Receptor–Positive Solid Tumors
  • Prognostic Value of Serial Cardiac 123I-MIBG Imaging in Patients with Stabilized Chronic Heart Failure and Reduced Left Ventricular Ejection Fraction
  • Quantitative Diagnostic Performance of Myocardial Perfusion SPECT with Attenuation Correction in Women
  • Radioiodine Therapy and Graves' Ophthalmopathy
  • The Cost-Effective Use of 18F-FDG PET in the Presurgical Evaluation of Medically Refractory Focal Epilepsy
  • Dual-Modality Imaging: Combining Anatomy and Function
  • Evaluation of the Efficacy of a Small CdTe γ-Camera for Sentinel Lymph Node Biopsy
  • Quantitation of CXCR4 Expression in Myocardial Infarction Using 99mTc-Labeled SDF-1α
  • Synthesis and Evaluation of a Series of 99mTc(CO)3+ Lisinopril Complexes for In Vivo Imaging of Angiotensin-Converting Enzyme Expression
  • Preclinical Development of a Neutral, Estrogen Receptor–Targeted, Tridentate 99mTc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative for Imaging of Breast and Endometrial Cancers
  • 7α-18F-Fluoromethyl-Dihydrotestosterone and 7α-18F-Fluoromethyl-Nortestosterone: Ligands to Determine the Role of Sex Hormone–Binding Globulin for Steroidal Radiopharmaceuticals
  • Comparison of 99mTc- and 18F-Ubiquicidin Autoradiography to Anti–Staphylococcus aureus Immunofluorescence in Rat Muscle Abscesses
  • Impact of Image-Space Resolution Modeling for Studies with the High-Resolution Research Tomograph
  • Lognormal Distribution of Cellular Uptake of Radioactivity: Statistical Analysis of α-Particle Track Autoradiography
  • Optimized 124I PET Dosimetry Protocol for Radioiodine Therapy of Differentiated Thyroid Cancer
  • Administered Radiopharmaceutical Doses in Children: A Survey of 13 Pediatric Hospitals in North America
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire